Jodi Devlin

CIK: 0001992151

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TLSI

TriSalus Life Sciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

TLSI
TriSalus Life Sciences, Inc.
Mar 16, 2026
Sale(S)
Direct
273 shares at avg. $4.12$1K
TLSI
TriSalus Life Sciences, Inc.
Mar 12, 2026
Sale(S)
Direct
1.8K shares at avg. $4.09$7K
TLSI
TriSalus Life Sciences, Inc.
Mar 11, 2026
Sale(S)
Direct
1.2K shares at avg. $4.13$5K
TLSI
TriSalus Life Sciences, Inc.
Nov 24, 2025
Award(A)
Direct
50K shares-
TLSI
TriSalus Life Sciences, Inc.
May 19, 2025
Sale(S)
Direct
4.8K shares at avg. $5.18$25K
TLSI
TriSalus Life Sciences, Inc.
May 19, 2025
Award(A)
Direct
24.1K shares at avg. $5.18$125K
TLSI
TriSalus Life Sciences, Inc.
Feb 18, 2025
Award(A)
Direct
5.3K shares-
TLSI
TriSalus Life Sciences, Inc.
Jan 27, 2025
Award(A)
Direct
10.6K shares-

		Type	Shares	Price		Ownership
Mar 16, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	273	$4.12	$1,125	Direct
Mar 12, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	1,772	$4.09	$7,247	Direct
Mar 11, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	1,162	$4.13	$4,799	Direct
Nov 24, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	50,000	-	-	Direct
May 19, 2025	TLSI TriSalus Life Sciences, Inc.	Sale(S)	4,764	$5.18	$24,678	Direct
May 19, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	24,131	$5.18	$124,999	Direct
Feb 18, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	5,272	-	-	Direct
Jan 27, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	10,625	-	$0	Direct

1-8 of 8 transactions

About Devlin Jodi

Devlin Jodi (SEC CIK 0001992151) files insider reports with the SEC as Chief of Clinical Operations of TriSalus Life Sciences, Inc. (TLSI).

Signal8 holds 5 ownership filings by Devlin Jodi, all Form 4s, filed between Jan 29, 2025 and Mar 20, 2026. Those filings report 8 transactions, from Jan 27, 2025 to Mar 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Devlin Jodi's filings is in WESTMINSTER, CO.

Recent filings by Devlin Jodi

Mar 16, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 12, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 11, 2026: Open-market sale of TLSI shares (Form 4, code S).
Nov 24, 2025: Grant or award of TLSI shares (Form 4, code A).
May 19, 2025: Open-market sale of TLSI shares (Form 4, code S).

Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)

Cox Bryan F., Chief of Research
Marshak Richard, Chief Commercial Officer
Stevens Jennifer, Chief Regulatory Officer
Szela Mary T, CEO and President
Patience David, Chief Financial Officer
Marshall Richard Henry, Chief Medical Officer

How to read Form 4 transaction codes